C E Pfeifle

979 total citations
23 papers, 776 citations indexed

About

C E Pfeifle is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, C E Pfeifle has authored 23 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Surgery and 6 papers in Pathology and Forensic Medicine. Recurrent topics in C E Pfeifle's work include Intraperitoneal and Appendiceal Malignancies (6 papers), Chemotherapy-induced organ toxicity mitigation (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). C E Pfeifle is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (6 papers), Chemotherapy-induced organ toxicity mitigation (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). C E Pfeifle collaborates with scholars based in United States. C E Pfeifle's co-authors include Stephen B. Howell, Maurie Markman, Richard A. Olshen, Maurie Markman, William E. Lucas, Stephen Cleary, Paul A. Andrews, Michael P. Murphy, Joseph J. Bookstein and Tanya Campbell and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The American Journal of Medicine.

In The Last Decade

C E Pfeifle

22 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C E Pfeifle United States 13 306 259 189 187 169 23 776
B Kabakow United States 15 208 0.7× 243 0.9× 147 0.8× 88 0.5× 331 2.0× 47 734
G. Lelli Italy 13 266 0.9× 368 1.4× 78 0.4× 223 1.2× 89 0.5× 46 876
James Raschko United States 20 223 0.7× 416 1.6× 112 0.6× 179 1.0× 49 0.3× 50 1.1k
Ellen Scheiner United States 7 166 0.5× 256 1.0× 221 1.2× 148 0.8× 26 0.2× 12 677
S. J. Harland United Kingdom 18 410 1.3× 390 1.5× 105 0.6× 219 1.2× 172 1.0× 32 1.1k
B Unsgaard Sweden 15 409 1.3× 408 1.6× 79 0.4× 261 1.4× 73 0.4× 25 1.1k
Robert E. Slayton United States 13 357 1.2× 213 0.8× 111 0.6× 193 1.0× 222 1.3× 37 802
I. Klein Netherlands 12 107 0.3× 275 1.1× 220 1.2× 62 0.3× 76 0.4× 16 668
Jiro Uozumi Japan 18 275 0.9× 209 0.8× 176 0.9× 225 1.2× 15 0.1× 69 838
Paul Thompson New Zealand 20 267 0.9× 311 1.2× 50 0.3× 165 0.9× 69 0.4× 44 1.1k

Countries citing papers authored by C E Pfeifle

Since Specialization
Citations

This map shows the geographic impact of C E Pfeifle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C E Pfeifle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C E Pfeifle more than expected).

Fields of papers citing papers by C E Pfeifle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C E Pfeifle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C E Pfeifle. The network helps show where C E Pfeifle may publish in the future.

Co-authorship network of co-authors of C E Pfeifle

This figure shows the co-authorship network connecting the top 25 collaborators of C E Pfeifle. A scholar is included among the top collaborators of C E Pfeifle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C E Pfeifle. C E Pfeifle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goel, Rakesh, Paul A. Andrews, C E Pfeifle, et al.. (1990). Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy. European Journal of Cancer and Clinical Oncology. 26(1). 21–27. 22 indexed citations
2.
Pfeifle, C E, Stephen B. Howell, William L. Ashburn, Robert M. Barone, & Joseph J. Bookstein. (1986). Pharmacologic Studies of Intra-Hepatic Artery Chemotherapy with Degradable Starch Microspheres. PubMed. 3(1). 1–14. 10 indexed citations
3.
Howell, Stephen B. & C E Pfeifle. (1986). Peritoneal Access for Intracavitary Chemotherapy. PubMed. 3(2). 157–161. 4 indexed citations
4.
Markman, Maurie, Stephen Cleary, C E Pfeifle, & Stephen B. Howell. (1986). Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma. Cancer. 58(1). 18–21. 73 indexed citations
5.
Pfeifle, C E, Stephen B. Howell, Ian Abramson, & Maurie Markman. (1985). Maintenance of Peritoneal Catheter Function by the Intraperitoneal Administration of 32% Dextran 70. PubMed. 2(4). 291–303. 1 indexed citations
6.
7.
Pfeifle, C E, et al.. (1985). High-dose cisplatin with sodium thiosulfate protection.. Journal of Clinical Oncology. 3(2). 237–244. 126 indexed citations
8.
Pfeifle, C E, Stephen B. Howell, & Maurie Markman. (1985). Intracavitary cisplatin chemotherapy for mesothelioma.. PubMed. 69(2). 205–7. 32 indexed citations
9.
Kaplan, Robert A., Maurie Markman, William E. Lucas, C E Pfeifle, & Stephen B. Howell. (1985). Infectious peritonitis in patients receiving intraperitoneal chemotherapy. The American Journal of Medicine. 78(1). 49–53. 30 indexed citations
10.
Markman, Maurie, et al.. (1984). Anaphylactic reaction to cytarabine: In vitro evidence that the response is immunoglobulin e mediated. Medical and Pediatric Oncology. 12(3). 201–203. 4 indexed citations
11.
Pfeifle, C E, et al.. (1984). Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma.. Journal of Clinical Oncology. 2(6). 662–669. 57 indexed citations
12.
Markman, Maurie, C E Pfeifle, & William E. Lucas. (1984). Severe intraoperative anaphylactic reaction to dextran 70 administered intraperitoneally.. PubMed. 141(5). 684–5. 1 indexed citations
13.
14.
Pfeifle, C E, Stephen B. Howell, Maurie Markman, & William E. Lucas. (1984). Totally implantable system for peritoneal access.. Journal of Clinical Oncology. 2(11). 1277–1280. 56 indexed citations
15.
Campbell, Tanya, et al.. (1983). Clinical pharmacokinetics of intraarterial cisplatin in humans.. Journal of Clinical Oncology. 1(12). 755–762. 41 indexed citations
16.
Howell, Stephen B., et al.. (1983). Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injection. Cancer. 51(2). 220–225. 16 indexed citations
17.
Howell, Stephen B., et al.. (1982). Modulation of the cellular pharmacology and clinical toxicity of 1-β-D-arabinofuranosylcytosine. Medical and Pediatric Oncology. 10(S1). 81–91. 8 indexed citations
18.
Kingston, Richard L., et al.. (1982). Comprehensive pharmaceutical services for a state correctional facility. American Journal of Health-System Pharmacy. 39(1). 86–89. 1 indexed citations
19.
Sb, Howell, et al.. (1982). High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule.. PubMed. 66(9). 1723–7. 8 indexed citations
20.
Pfeifle, C E, et al.. (1981). Phenytoin sodium solubility in three intravenous solutions. American Journal of Health-System Pharmacy. 38(3). 358–362. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Kabakow Breakdown of academic impact, for papers by G. Lelli Breakdown of academic impact, for papers by James Raschko Breakdown of academic impact, for papers by Ellen Scheiner Breakdown of academic impact, for papers by S. J. Harland Breakdown of academic impact, for papers by B Unsgaard Breakdown of academic impact, for papers by Robert E. Slayton Breakdown of academic impact, for papers by I. Klein Breakdown of academic impact, for papers by Jiro Uozumi Breakdown of academic impact, for papers by Paul Thompson
Rankless by CCL
2026